These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12970144)

  • 1. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
    Lemonde HA; Custard EJ; Bouquet J; Duran M; Overmars H; Scambler PJ; Clayton PT
    Gut; 2003 Oct; 52(10):1494-9. PubMed ID: 12970144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency.
    Ueki I; Kimura A; Chen HL; Yorifuji T; Mori J; Itoh S; Maruyama K; Ishige T; Takei H; Nittono H; Kurosawa T; Kage M; Matsuishi T
    J Gastroenterol Hepatol; 2009 May; 24(5):776-85. PubMed ID: 19175828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing primary from secondary Δ(4) -3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis.
    Yanagi T; Mizuochi T; Homma K; Ueki I; Seki Y; Hasegawa T; Takei H; Nittono H; Kurosawa T; Matsuishi T; Kimura A
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):346-51. PubMed ID: 25154774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two neonatal cholestasis patients with mutations in the SRD5B1 (AKR1D1) gene: diagnosis and bile acid profiles during chenodeoxycholic acid treatment.
    Seki Y; Mizuochi T; Kimura A; Takahashi T; Ohtake A; Hayashi S; Morimura T; Ohno Y; Hoshina T; Ihara K; Takei H; Nittono H; Kurosawa T; Homma K; Hasegawa T; Matsuishi T
    J Inherit Metab Dis; 2013 May; 36(3):565-73. PubMed ID: 23160874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes.
    Zhang MH; Setchell KD; Zhao J; Gong JY; Lu Y; Wang JS
    World J Gastroenterol; 2019 Feb; 25(7):859-869. PubMed ID: 30809085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect.
    Gonzales E; Cresteil D; Baussan C; Dabadie A; Gerhardt MF; Jacquemin E
    J Hepatol; 2004 Apr; 40(4):716-8. PubMed ID: 15030995
    [No Abstract]   [Full Text] [Related]  

  • 7. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
    Clayton PT; Mills KA; Johnson AW; Barabino A; Marazzi MG
    Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid Treatment.
    Kimura A; Mizuochi T; Takei H; Ohtake A; Mori J; Shinoda K; Hashimoto T; Kasahara M; Togawa T; Murai T; Iida T; Nittono H
    Dig Dis Sci; 2021 Nov; 66(11):3885-3892. PubMed ID: 33385262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.
    Setchell KD; Suchy FJ; Welsh MB; Zimmer-Nechemias L; Heubi J; Balistreri WF
    J Clin Invest; 1988 Dec; 82(6):2148-57. PubMed ID: 3198770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary ∆4-3-oxosteroid 5β-reductase deficiency: two cases in China.
    Zhao J; Fang LJ; Setchell KD; Chen R; Li LT; Wang JS
    World J Gastroenterol; 2012 Dec; 18(47):7113-7. PubMed ID: 23323017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis.
    Siafakas CG; Jonas MM; Perez-Atayde AR
    J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):321-6. PubMed ID: 9285385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of bile acids in snake bile using ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Zhang J; Peng J; Chen X; Gong Y; Wan L; Gao F; Gan S; Wei F; Ma S; Chen J; Nie J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():157-169. PubMed ID: 27760405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases.
    Chen JY; Wu JF; Kimura A; Nittono H; Liou BY; Lee CS; Chen HS; Chiu YC; Ni YH; Peng SS; Lee WT; Tsai IJ; Chang MH; Chen HL
    Pediatr Neonatol; 2020 Feb; 61(1):75-83. PubMed ID: 31337596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Delta4-3-oxosteroid 5beta-reductase (AKR1D1) deficiency and steroid metabolism.
    Palermo M; Marazzi MG; Hughes BA; Stewart PM; Clayton PT; Shackleton CH
    Steroids; 2008 Apr; 73(4):417-23. PubMed ID: 18243262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ∆
    Gardin A; Ruiz M; Beime J; Cananzi M; Rathert M; Rohmer B; Grabhorn E; Almes M; Logarajah V; Peña-Quintana L; Casswall T; Darmellah-Remil A; Reyes-Domínguez A; Barkaoui E; Hierro L; Baquero-Montoya C; Baumann U; Fischler B; Gonzales E; Davit-Spraul A; Laplanche S; Jacquemin E
    Orphanet J Rare Dis; 2023 Dec; 18(1):383. PubMed ID: 38062451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infant cholestasis patient with a novel missense mutation in the
    Wang HH; Wen FQ; Dai DL; Wang JS; Zhao J; Setchell KD; Shi LN; Zhou SM; Liu SX; Yang QH
    World J Gastroenterol; 2018 Sep; 24(35):4086-4092. PubMed ID: 30254413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dried blood spot-based newborn screening for bile acid synthesis disorders, Zellweger spectrum disorder, and Niemann-Pick type C1 by detection of bile acid metabolites.
    Muto Y; Suzuki M; Takei H; Saito N; Mori J; Sugimoto S; Imagawa K; Nambu R; Oguri S; Itonaga T; Ihara K; Hayashi H; Murayama K; Kakiyama G; Nittono H; Shimizu T
    Mol Genet Metab; 2023; 140(1-2):107703. PubMed ID: 37802748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis.
    Shneider BL; Setchell KD; Whitington PF; Neilson KA; Suchy FJ
    J Pediatr; 1994 Feb; 124(2):234-8. PubMed ID: 8301429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC-ESI-MS/MS measurement of urinary bile acids.
    Muto A; Takei H; Unno A; Murai T; Kurosawa T; Ogawa S; Iida T; Ikegawa S; Mori J; Ohtake A; Hoshina T; Mizuochi T; Kimura A; Hofmann AF; Hagey LR; Nittono H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():24-31. PubMed ID: 22695323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.